Omada Health, Inc.Omada Health, Inc.Omada Health, Inc.

Omada Health, Inc.

No trades
No trades

Compare with Omada Health, Inc.



Key facts today


JP Morgan kept Omada Health (OMDA) Overweight and raised its price target to $30 from $26, signaling updated analyst outlook and higher valuation for the stock. 1
Analyze the impactAnalyze the impact
Market capitalization
‪1.49 B‬USD
0.07USD
‪−12.78 M‬USD
‪260.21 M‬USD
‪28.41 M‬
Beta (1Y)
1.45
Last report date
Aug 6, 2026
Report period
Q2 2026
EPS
0.18USD
Revenue
‪87.83 M‬USD
Earnings call summary

Record Q2 results featured 43% revenue growth, 73% GAAP gross margin, and $5M net income, prompting raised full-year guidance. Diabetes and Hypertension programs led growth, while new offerings like cholesterol and GLP-1 prescribing expanded the addressable market.

Employees (FY)
916
Change (1Y)
+67+7.89%
Revenue / Employee (1Y)
‪284.07 K‬USD
Net income / Employee (1Y)
‪−13.95 K‬USD

Details


CEO
Sean Duffy
Headquarters
South San Francisco
Founded
2011
IPO date
Jun 6, 2025
ISIN
US68170A1088
CUSIP
68170A108
FIGI
BBG005TP6Y82
Identifiers
ISIN US68170A1088
CFI code
ESVUFR
Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in South San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.03%
Market value‪21.80 M‬
Weight0.05%
Market value‪7.80 M‬
Weight0.05%
Market value‪3.43 M‬
Weight0.01%
Market value‪1.27 M‬
Weight0.05%
Market value‪837.83 K‬
Weight0.03%
Market value‪824.46 K‬
Weight0.22%
Market value‪761.15 K‬
Weight0.56%
Market value‪577.18 K‬
Weight0.03%
Market value‪412.41 K‬
Weight0.04%
Market value‪367.14 K‬

Explore more ETFs 

Frequently asked questions


The current price of OMDA is 24.04 USD — it has increased by 2.22% in the past 24 hours. Watch Omada Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omada Health, Inc. stocks are traded under the ticker OMDA.
OMDA stock has risen by 29.77% compared to the previous week, the month change is a 6.00% rise, over the last year Omada Health, Inc. has showed a 21.48% increase.
We've gathered analysts' opinions on Omada Health, Inc. future price: according to them, OMDA price has a max estimate of 35.00 USD and a min estimate of 22.00 USD. Watch OMDA chart and read a more detailed Omada Health, Inc. stock forecast: see what analysts think of Omada Health, Inc. and suggest that you do with its stocks.
OMDA reached its all-time high on Jun 6, 2025 with the price of 28.40 USD, and its all-time low was 10.28 USD and was reached on Feb 11, 2026. View more price dynamics on OMDA chart.
See other stocks reaching their highest and lowest prices.
OMDA stock is 4.55% volatile and has beta coefficient of 1.45. Track Omada Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Omada Health, Inc. there?
Today Omada Health, Inc. has the market capitalization of ‪1.49 B‬, it has decreased by −6.46% over the last week.
Yes, you can track Omada Health, Inc. financials in yearly and quarterly reports right on TradingView.
Omada Health, Inc. is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
OMDA earnings for the last quarter are 0.18 USD per share, whereas the estimation was 0.06 USD resulting in a 189.39% surprise. The estimated earnings for the next quarter are 0.08 USD per share. See more details about Omada Health, Inc. earnings.
Omada Health, Inc. revenue for the last quarter amounts to ‪87.83 M‬ USD, despite the estimated figure of ‪80.04 M‬ USD. In the next quarter, revenue is expected to reach ‪85.47 M‬ USD.
OMDA net income for the last quarter is ‪5.29 M‬ USD, while the quarter before that showed ‪−2.97 M‬ USD of net income which accounts for 0.00% change. Track more Omada Health, Inc. financial stats to get the full picture.
No, OMDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 14, 2026, the company has 916 employees. See our rating of the largest employees — is Omada Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Omada Health, Inc. EBITDA is ‪5.43 M‬ USD, and current EBITDA margin is −2.49%. See more stats in Omada Health, Inc. financial statements.
Like other stocks, OMDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omada Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omada Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omada Health, Inc. stock shows the strong buy signal. See more of Omada Health, Inc. technicals for a more comprehensive analysis.